Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Americans overspend $73bn on branded drugs

Doctors may be encouraged to prescribe lower-cost generics, but a new study found that Americans spent an extra $73 billion between 2010 and 2012 on pricier brand-name drugs because physicians failed to sufficiently recommend these copycat treatments to their patients. And consumers paid nearly one-third of those additional costs through out-of-pocket payments. Notably, the study found…

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact us or visit

Back to DrugPatentWatch Resources

For more information try a trial or see the database preview and plans and pricing